Phase 3 Endometrial Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You have been diagnosed with cervical cancer at a certain stage (moderately advanced to advanced, known as FIGO 2018 stage IB3 to IVA).
- You have already received standard treatment combining chemotherapy and radiation therapy (chemoradiotherapy).
- You are generally well enough to carry out normal daily activities, as measured by a standard health score, and are expected to live at least 12 weeks.
- Your immune system is functioning normally.
- A blood test taken after your chemoradiotherapy found traces of certain types of HPV (a virus linked to cervical cancer) in your bloodstream.
- Your blood counts, liver, and kidney are working well enough to meet specific health thresholds (confirm with trial site for exact values).
- If you are able to become pregnant, you must be willing to use an approved form of contraception during the trial and for 3 months after it ends.
- You are willing to take part and have signed a consent form agreeing to the study procedures.
Who may not be able to join:
- You have had cervical cancer before, or have had any other type of cancer.
- You are currently pregnant.
- You were unable to complete the standard chemotherapy and radiation treatment that was required before joining the trial.
- Your tumor contains HPV types other than the specific ones listed in the trial criteria (confirm with trial site).
- You do not have tissue biopsy results confirming your diagnosis, or you have not had the required tests to determine the stage of your cancer.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 11 999112805
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Progression free survival
Can't join this trial?
Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.